Double-minute MYC amplification and deletion of MTAP, CDKN2A, CDKN2B, and ELAVL2 in an acute myeloid leukemia characterized by oligonucleotide-array comparative genomic hybridization

Cancer Genetics and Cytogenetics

Volumn 183, Issue 2, 2008, Pages 117-120

  Kamath, Anitha ^a   Tara, Harold ^b   Xiang, Bixia ^a   Bajaj, Renu ^a   He, Wanping ^a   Li, Peining ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b McGivney Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; FIBRIN; FIBRINOGEN; HYDROXYUREA;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; BLOOD CLOTTING; BLOOD SMEAR; CASE REPORT; CELL STRUCTURE; CHROMOSOME TRANSLOCATION; DISEASE PREDISPOSITION; DNA HYBRIDIZATION; DNA MICROARRAY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; GENE PROBE; HEMATOCRIT; HUMAN; LEUKOCYTE COUNT; MOLECULAR CLONING; MONOSOMY; ONCOGENE MYC; PRIORITY JOURNAL; THROMBOCYTE COUNT; X CHROMOSOME;

AGED; AGED, 80 AND OVER; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENES, MYC; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, ACUTE; MICROTUBULE-ASSOCIATED PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

BACTERIA (MICROORGANISMS);

EID: 43949140892     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.02.011     Document Type: Article

References (15)

1. Kearney L., and Horsley S.W. Molecular cytogenetics in haematological malignancy: current technology and future prospects. Chromosoma 114 (2005) 286-294
2. Kallioniemi A., Kallioniemi O.P., Sudar D., Rutovitz D., Gray J.W., Waldman F., and Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258 (1992) 818-821
3. Levene A.P., Morgan G.J., and Davies F.E. The use of genetic microarray analysis to classify and predict prognosis in haematological malignancies. Clin Lab Haematol 25 (2003) 209-220
4. Inazawa J., Inoue J., and Imoto I. Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes. Cancer Sci 95 (2004) 559-563
5. Li P., Zhang H.Z., Huff S., Nimmakayalu M., Qumsiyeh M., Yu J.W., Szekely A., Xu T., and Pober B.R. Karyotype-phenotype insights from 11q14.1-q23.2 interstitial deletions: FZD4 haploinsufficiency and exudative vitreoretinopathy in a patient with a complex chromosome rearrangement. Am J Med Genet A 140 (2006) 2721-2729
6. Maddika S., Ande S.R., Panigrahi S., Paranjothy T., Weglarczyk K., Zuse A., Eshraghi M., Manda K.D., Wiechec E., and Los M. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist Updat 10 (2007) 13-29
7. Petty E.M., Gibson L.H., Fountain J.W., Bolognia J.L., Yang-Feng T.L., Housman D.E., and Bale A.E. Molecular definition of a chromosome 9p21 germ-line deletion in a woman with multiple melanomas and a plexiform neurofibroma: implications for 9p tumor suppressor gene(s). Am J Hum Genet 53 (1994) 96-104
8. Nobori T., Miura K., Wu D.J., Lois A., Takabayashi K., and Carson D.A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368 (1994) 753-756
9. Lindor M.L., Jalal S.M., Kumar S., and Lteif A.N. Multiple primary tumors associated with chromosome 9p deletion. Am J Med Genet A 143 (2007) 95-97
10. INK4B gene deletions in primary leukemias. Blood 86 (1995) 311-315
11. Slovak M.L., Ho J.P., Pettenati M.J., Khan A., Douer D., Lal S., and Traweek S.T. Localization of amplified MYC gene sequences to double minute chromosomes in acute myelogenous leukemia. Genes Chromosomes Cancer 9 (1994) 62-67
12. Sait N.J.S., Qadir M.U., Conroy J.M., Matsui S., Nowak N.J., and Baer M.R. Double minute chromosomes in acute myeloid leukemia and myelodysplastic syndrome: identification of new amplification regions by fluorescence in situ hybridization and spectral karyotyping. Genes Chromosomes Cancer 34 (2002) 42-47
13. Storlazzi C.T., Fioretos T., Surace C., Lonoce A., Mastrorilli A., Strömbeck B., D'Addabbo P., Iacovelli F., Minervini C., Aventin A., Dastugue N., Fonatsch C., Hagemeijer A., Jotterand M., Mühlematter D., Lafage-Pochitaloff M., Nguyen-Khac F., Schoch C., Slovak M.L., Smith A., Solè F., Van Roy N., Johansson B., and Rocchi M. MYC-containing double minutes in hematologic malignancies: evidence in favor of the epidome model and exclusion of MYC as the target gene. Hum Mol Genet 15 (2006) 933-942
14. Thomas L., Stamberg J., Gojo I., Ning Y., and Rapoport A.P. Double minute chromosomes in monoblastic (M5) and myeloblastic (M2) acute myeloid leukemia: two case reports and a review of literature. Am J Hematol 77 (2004) 55-61
15. Bruckert P., Kappler R., Scherthan H., Link H., Hagmann F.G., and Zankl H. Double minutes and c-MYC amplification in acute myelogenous leukemia: are they prognostic factors?. Cancer Genet Cytogenet 120 (2000) 73-79